Vivos Therapeutics (VVOS) Short Interest Ratio & Short Volume $4.20 -0.40 (-8.70%) Closing price 04:00 PM EasternExtended Trading$4.22 +0.02 (+0.48%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vivos Therapeutics Short Interest DataVivos Therapeutics (VVOS) has a short interest of 251,800 shares, representing 7.89% of the float (the number of shares available for trading by the public). This marks a -18.88% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 177,701 shares to cover all short positions.Current Short Interest251,800 sharesPrevious Short Interest310,400 sharesChange Vs. Previous Month-18.88%Dollar Volume Sold Short$1.09 millionShort Interest Ratio0.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares7,500,000 sharesFloat Size3,190,000 sharesShort Percent of Float7.89%Today's Trading Volume163,316 sharesAverage Trading Volume177,701 sharesToday's Volume Vs. Average92% Short Selling Vivos Therapeutics? Sign up to receive the latest short interest report for Vivos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVVOS Short Interest Over TimeVVOS Days to Cover Over TimeVVOS Percentage of Float Shorted Over Time Vivos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025251,800 shares $1.09 million -18.9%7.9%0.3 $4.33 7/15/2025310,400 shares $2.09 million +248.0%9.7%0.4 $6.74 6/30/202589,200 shares $281.87 thousand -71.0%1.6%0.2 $3.16 6/15/2025307,200 shares $657.41 thousand +0.6%8.2%2.5 $2.14 5/31/2025305,500 shares $720.98 thousand +48.3%6.7%3.2 $2.36 5/15/2025206,000 shares $630.36 thousand -20.6%4.5%1.9 $3.06 4/30/2025259,400 shares $736.70 thousand +17.6%5.7%2.3 $2.84 4/15/2025220,600 shares $483.11 thousand -23.3%4.8%1.7 $2.19 3/31/2025287,700 shares $819.95 thousand +15.5%6.3%1.6 $2.85 3/15/2025249,000 shares $821.70 thousand -27.6%5.4%1.2 $3.30 Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025344,000 shares $1.19 million +22.1%7.5%1.5 $3.47 2/15/2025281,700 shares $1.13 million +0.1%6.1%1.1 $4.00 1/31/2025281,400 shares $1.12 million +3.1%6.1%1.1 $3.97 1/15/2025273,000 shares $1.40 million +134.9%6.3%1.1 $5.12 12/31/2024116,200 shares $498.50 thousand -21.5%2.7%0.6 $4.29 12/15/2024148,000 shares $682.28 thousand +28.9%3.9%0.7 $4.61 11/30/2024114,800 shares $391.47 thousand -12.2%2.7%0.1 $3.41 11/15/2024130,800 shares $371.47 thousand +37.5%3.0%0.1 $2.84 10/31/202495,100 shares $239.65 thousand +36.3%2.2%0.1 $2.52 10/15/202469,800 shares $172.41 thousand -25.4%1.6%0.1 $2.47 9/30/202493,600 shares $244.30 thousand +46.9%2.3%0.1 $2.61 9/15/202463,700 shares $187.92 thousand +12.0%2.0%0 $2.95 8/31/202456,900 shares $154.20 thousand -34.9%1.8%0.9 $2.71 8/15/202487,400 shares $194.90 thousand +54.7%2.7%1.4 $2.23 7/31/202456,500 shares $129.95 thousand -3.9%1.8%0.9 $2.30 7/15/202458,800 shares $164.05 thousand -40.1%1.8%0.9 $2.79 6/30/202498,100 shares $217.78 thousand +92.0%3.1%0.7 $2.22 6/15/202451,100 shares $114.98 thousand +5.6%1.6%0.3 $2.25 5/31/202448,400 shares $101.16 thousand +4.3%1.6%0.3 $2.09 5/15/202446,400 shares $101.15 thousand -26.1%1.6%0.3 $2.18 4/30/202462,800 shares $158.88 thousand -67.1%2.3%0.3 $2.53 4/15/2024191,100 shares $529.35 thousand +921.9%7.6%0.9 $2.77 3/31/202418,700 shares $90.32 thousand -28.6%0.8%0.1 $4.83 3/15/202426,200 shares $117.90 thousand +11.0%2.3%0.2 $4.50 2/29/202423,600 shares $137.12 thousand -19.2%2.1%0.1 $5.81 2/15/202429,200 shares $156.51 thousand -38.1%2.6%0 $5.36 1/31/202447,200 shares $347.86 thousand +237.1%4.2%0 $7.37 1/15/202414,000 shares $111.30 thousand -84.0%1.2%0 $7.95 12/31/202387,300 shares $1.09 million -46.2%N/A0 $12.44 12/15/2023162,300 shares $1.49 million +512.5%14.6%0.1 $9.21The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 11/30/202326,500 shares $649.25 thousand -31.2%2.4%0 $24.50 11/15/202338,500 shares $148.23 thousand +13.2%3.9%0.2 $3.85 10/31/202334,000 shares $109.14 thousand -98.5%3.4%0.2 $3.21 10/15/20232,270,000 shares $732.30 thousand +297.1%N/A0.4 $0.32 9/30/2023571,600 shares $109.80 thousand +8.3%N/A0.1 $0.19 9/15/2023527,700 shares $129.29 thousand -18.9%N/A0.3 $0.25 8/31/2023650,300 shares $163.42 thousand -43.0%N/A0.4 $0.25 8/15/20231,140,000 shares $372.10 thousand +1,388.3%N/A0.7 $0.33 7/31/202376,600 shares $22.29 thousand -33.6%N/A0.1 $0.29 7/15/2023115,300 shares $36.49 thousand +63.3%N/A0.5 $0.32 6/30/202370,600 shares $36.01 thousand -69.7%N/A0.5 $0.51 6/15/2023232,900 shares $128.42 thousand -5.2%N/A1.4 $0.55 5/31/2023245,600 shares $93.72 thousand +11.5%N/A1.3 $0.38 5/15/2023220,200 shares $72.67 thousand +48.1%N/A0.3 $0.33 4/30/2023148,700 shares $51.15 thousand -21.9%N/A0.2 $0.34 4/15/2023190,400 shares $63.57 thousand +31.7%N/A0.3 $0.33 3/31/2023144,600 shares $49.32 thousand -45.1%N/A0.2 $0.34 3/15/2023263,500 shares $96.60 thousand +449.0%1.3%0.1 $0.37 2/28/202348,000 shares $29.28 thousand -82.9%0.2%0 $0.61 2/15/2023281,000 shares $256.38 thousand -5.9%1.4%0.1 $0.91 1/31/2023298,700 shares $325.58 thousand -65.5%1.7%0.1 $1.09 1/15/2023865,100 shares $1.51 million +576.4%4.8%0.4 $1.75 12/30/2022127,900 shares $51.42 thousand +10.6%0.7%0.1 $0.40 12/15/2022115,600 shares $40.29 thousand -16.4%0.6%1.6 $0.35 11/30/2022138,200 shares $69.10 thousand -17.8%0.8%3.5 $0.50 11/15/2022168,200 shares $115.37 thousand -22.8%0.9%4.9 $0.69 10/31/2022217,900 shares $156.89 thousand +29.0%1.2%5.2 $0.72 10/15/2022168,900 shares $116.00 thousand -0.2%0.9%4 $0.69 9/30/2022169,300 shares $110.03 thousand +19.1%0.9%4.2 $0.65 9/15/2022142,100 shares $161.99 thousand -20.9%0.8%3.8 $1.14 8/31/2022179,600 shares $220.91 thousand +26.5%1.0%4.3 $1.23 8/15/2022142,000 shares $200.22 thousand -43.6%0.8%3 $1.41 7/31/2022251,600 shares $289.34 thousand +19.9%1.4%5.3 $1.15 7/15/2022209,800 shares $295.82 thousand -17.4%1.2%3.9 $1.41 6/30/2022254,100 shares $327.79 thousand -3.6%1.5%4.3 $1.29 6/15/2022263,500 shares $337.28 thousand -32.5%1.5%3.5 $1.28 5/31/2022390,500 shares $792.72 thousand -4.9%2.3%4.9 $2.03 5/15/2022410,700 shares $570.87 thousand +50.6%2.4%3.5 $1.39 4/30/2022272,800 shares $471.94 thousand -32.2%1.6%1.9 $1.73 4/15/2022402,300 shares $788.51 thousand -16.8%2.3%0.8 $1.96 3/31/2022483,600 shares $1.30 million -5.7%2.8%0.2 $2.68 3/15/2022512,900 shares $1.38 million -31.4%3.0%0.2 $2.69 2/28/2022747,700 shares $2.50 million +54.3%4.3%0.4 $3.34 2/15/2022484,700 shares $1.17 million -60.6%2.8%0.2 $2.42 1/31/20221,230,000 shares $3.04 million +760.1%7.1%0.6 $2.47 1/15/2022143,000 shares $267.41 thousand -10.8%1.0%0.1 $1.87 12/31/2021160,300 shares $360.68 thousand -15.8%1.2%1.2 $2.25 12/15/2021190,400 shares $531.22 thousand -36.6%1.4%1.3 $2.79 11/30/2021300,300 shares $765.77 thousand -19.0%2.2%1.4 $2.55 11/15/2021370,800 shares $1.51 million -11.6%2.7%1.1 $4.06The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 10/29/2021419,400 shares $1.52 million +41.6%3.1%0.1 $3.63 10/15/2021296,200 shares $1.05 million +3.6%2.2%0.1 $3.55 9/30/2021285,800 shares $1.15 million -0.1%2.1%0.1 $4.04 9/15/2021286,200 shares $1.35 million -56.2%2.1%0.1 $4.73 8/31/2021652,700 shares $3.43 million +1,390.2%4.8%0.2 $5.26 8/13/202143,800 shares $143.23 thousand -25.8%0.3%0 $3.27 7/30/202159,000 shares $178.18 thousand -50.7%0.4%0.2 $3.02 7/15/2021119,700 shares $514.71 thousand +193.4%0.9%0.4 $4.30 6/30/202140,800 shares $201.96 thousand -17.7%0.3%0.1 $4.95 6/15/202149,600 shares $288.18 thousand -22.0%0.4%0.3 $5.81 5/28/202163,600 shares $342.17 thousand +1.0%0.5%0.3 $5.38 5/14/202163,000 shares $372.96 thousand +90.3%0.5%0.4 $5.92 4/30/202133,100 shares $223.43 thousand -45.7%0.3%0.2 $6.75 4/15/202160,900 shares $542.01 thousand +45.4%0.6%0.3 $8.90 3/31/202141,900 shares $283.66 thousand +165.2%0.4%0.2 $6.77 3/15/202115,800 shares $117.55 thousand -31.9%0.2%0.1 $7.44 2/26/202123,200 shares $174.93 thousand -33.9%0.2%0 $7.54 2/12/202135,100 shares $245.35 thousand +317.9%0.3%0.1 $6.99 1/29/20218,400 shares $56.66 thousand -88.0%0.1%0 $6.75 1/15/202170,100 shares $560.10 thousand No Change0.6%0.1 $7.99 VVOS Short Interest - Frequently Asked Questions What is Vivos Therapeutics' current short interest? Short interest is the volume of Vivos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 251,800 shares of VVOS short. 7.89% of Vivos Therapeutics' shares are currently sold short. Learn More on Vivos Therapeutics' current short interest. What is a good short interest percentage for Vivos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.89% of Vivos Therapeutics' floating shares are currently sold short. Is Vivos Therapeutics' short interest increasing or decreasing? Vivos Therapeutics saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 251,800 shares, a drop of 18.9% from the previous total of 310,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vivos Therapeutics' float size? Vivos Therapeutics currently has issued a total of 7,500,000 shares. Some of Vivos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vivos Therapeutics currently has a public float of 3,190,000 shares. How does Vivos Therapeutics' short interest compare to its competitors? 7.89% of Vivos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Vivos Therapeutics: Jin Medical International Ltd. (0.26%), Fonar Corporation (0.92%), Hyperfine, Inc. (4.46%), enVVeno Medical Corporation (2.86%), Apyx Medical Corporation (0.99%), Vivani Medical, Inc. (1.23%), Nutriband Inc. (1.27%), TELA Bio, Inc. (1.19%), Pulmonx Corporation (3.61%), Cytosorbents Corporation (2.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Vivos Therapeutics stock? Short selling VVOS is an investing strategy that aims to generate trading profit from Vivos Therapeutics as its price is falling. VVOS shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vivos Therapeutics? A short squeeze for Vivos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VVOS, which in turn drives the price of the stock up even further. How often is Vivos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVOS, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ZJYL Short Interest FONR Short Interest HYPR Short Interest NVNO Short Interest APYX Short Interest VANI Short Interest NTRB Short Interest TELA Short Interest LUNG Short Interest CTSO Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VVOS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access